Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna Inc.

In a report released today, Cory Kasimov from Evercore ISI maintained a Hold rating on Moderna, with a price target of $28.00. According to TipRank...

Evercore ISI Remains a Hold on Moderna (MRNA)

RBC Capital analyst Luca Issi reiterated a Hold rating on Moderna yesterday and set a price target of $25.00. The company’s shares closed yesterday...

RBC Capital Reaffirms Their Hold Rating on Moderna (MRNA)

The Vanguard S&P 500 ETF ($VOO) gained 0.36% on Wednesday, snapping a four-day slide. The ETF is also up 1.10% in pre-market trading today after Nv...

Vanguard S&P 500 ETF (VOO) Daily Update, 11/20/2025

Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year and over 85% in three...

Moderna Stock (MRNA) Faces a Cash Crunch Test as Analyst Day Arrives

The SPDR S&P 500 ETF Trust ($SPY) closed 0.02% lower on Friday. Volatility in the technology sector and concerns about a potential delay in Federal...

SPY ETF Daily Update, 11/14/2025

Moderna ( ($MRNA) ) has provided an update. On November 12, 2025, Moderna, Inc. held a Special Meeting of Shareholders where two proposals were app...

Moderna Approves Stock Option Exchange Program

The SPDR S&P 500 ETF Trust ($SPY) gained 0.23% on Tuesday. A key factor that supported its performance today includes a “relief rally” spurred by h...

SPY ETF Daily Update, 11/11/2025

How is VOO stock faring? The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index ($SPX), is down 0.21% in pre-market trading today. The dip...

VOO ETF Daily Update, 11/11/2025

Analysts fell to the sidelines weighing in on Neumora Therapeutics, Inc. (NMRA – Research Report) and Moderna (MRNA – Research Report) with neutral...

Analysts Are Neutral on Top Healthcare Stocks: Neumora Therapeutics, Inc. (NMRA), Moderna (MRNA)

How is VOO stock faring? The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 (SPX), is up 0.10% in pre-market trading today, helped by a stro...

VOO ETF Daily Update, 11/6/2025

The SPDR S&P 500 ETF Trust ($SPY) gained 0.35% on Wednesday, primarily due to a stronger-than-expected ADP private payrolls report. Meanwhile, conc...

SPY ETF Daily Update, 11/5/2025

How is VOO stock faring? The Vanguard S&P 500 ETF&nbsp;($VOO), which tracks the S&P 500 (SPX), is down 0.20% in pre-market trading today. &nbsp;The...

VOO ETF Daily Update, 11/5/2025

The SPDR S&P 500 ETF Trust ($SPY) gained 0.19% on Monday. Key factors influencing the market today include comments from Fed officials dimming hope...

SPY ETF Daily Update, 11/3/2025

How is VOO stock faring? The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 (SPX), is up 0.43% in pre-market trading today, supported by str...

VOO ETF Daily Update, 11/3/2025

Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining COVID-related revenues a...

Moderna Stock (MRNA) Surges 17% on Buyout Speculation ahead of Q3 Earnings

The SPDR S&P 500 ETF Trust ($SPY) gained 0.05% on Wednesday, fueled by optimism over artificial intelligence (AI) stocks, especially Nvidia ($NVDA)...

SPY ETF Daily Update, 10/29/2025

The SPDR S&P 500 ETF Trust ($SPY) gained 0.27% on Tuesday. Importantly, the ETF hit a new all-time high of $688.90 during the day. The upside was d...

SPY ETF Daily Update, 10/28/2025

Bernstein analyst Courtney Breen maintained a Hold rating on Moderna yesterday and set a price target of $25.00. The company’s shares closed yester...

Bernstein Sticks to Its Hold Rating for Moderna (MRNA)

How is VOO stock faring? The Vanguard S&P 500 ETF is up 1.28% in the past five days and 16.63% year-to-date.&nbsp; Fund Flows and Sentiment The VOO...

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRNA	$23.72	+6.08%	13.90M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRNA	$23.72	+6.1%	13.90M
3
4
5
6

MRNA

MRNA

Dividend Overview

Get Moderna Inc. Data in Excel

Get Moderna Inc. Data in Excel